{"id":2018,"date":"2017-12-31T00:00:38","date_gmt":"2017-12-30T17:00:38","guid":{"rendered":"https:\/\/www.hivnat.org\/en\/?p=2018"},"modified":"2022-03-30T10:05:34","modified_gmt":"2022-03-30T03:05:34","slug":"a-phase-iii-open-label-safety-study-of-elvitegravir-cobicistat-emtricitabine-tenofovir-alafenamide-single-tablet-regimen-in-hiv-1-positive-patients-with-mild-to-moderate-renal-impairment","status":"publish","type":"post","link":"https:\/\/www.hivnat.org\/en\/studies\/2018\/","title":{"rendered":"A phase 3 open-label safety study of Elvitegravir\/Cobicistat\/Emtricitabine\/Tenofovir Alafenamide single-tablet regimen in HIV-1 positive patients with mild to moderate renal impairment"},"content":{"rendered":"\n<p>Open-label, multicenter, multi-cohort\nstudy to assess the safety, tolerability, and efficacy of a STR of E\/C\/F\/TAF in\nHIV-positive, adult subjects with mild to moderate renal impairment.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\t\t\t\tOpen-label, multicenter, multi-cohort study to assess the safety, tolerability, and efficacy of a STR of E\/C\/F\/TAF in HIV-positive, adult subjects with mild to moderate renal impairment.\t\t<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[24],"tags":[],"class_list":["post-2018","post","type-post","status-publish","format-standard","hentry","category-studies"],"_links":{"self":[{"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/posts\/2018","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/comments?post=2018"}],"version-history":[{"count":1,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/posts\/2018\/revisions"}],"predecessor-version":[{"id":3337,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/posts\/2018\/revisions\/3337"}],"wp:attachment":[{"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/media?parent=2018"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/categories?post=2018"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/tags?post=2018"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}